Boothbay Fund Management »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.5M 4.4M 1.71
2024-06-30 $9.5M 4.4M 2.16
2024-03-31 $6.3M 3.5M 1.79
2023-09-30 $6.9M 3.9M 1.77
2023-06-30 $4.4M 2.5M 1.75
2021-03-31 $5.6M 4.3M 1.30

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dell Technologies CL C Call Option (DELL)
Select Sector Spdr Tr Indl Put Option (XLI)
Cornerstone Strategic Value (CLM)
NVIDIA Corporation Put Option (NVDA)
Take-Two Interactive Software (TTWO)
Sba Communications Corp Cl A (SBAC)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Netflix (NFLX)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Elanco Animal Health Call Option (ELAN)
Amphenol Corp Cl A (APH)
Western Digital Call Option (WDC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Equinix (EQIX)

View all positions for Boothbay Fund Management

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
D. E. Shaw & Co
Capstone Investment Advisors
CSS
Boothbay Fund Management
Elequin Capital
Warberg Asset Management
Palisade Capital Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Citigroup
Jpmorgan Chase & Co
UBS Group
Bank of America Corporation

View all funds holding Sarepta Therapeutics note 1.500% 11/1